Sector ratings Johnson & Johnson

Equities

Market Closed - Nyse Other stock markets 04:00:02 2026-02-06 pm EST			5-day change	1st Jan Change
239.99 ^USD	+0.93%		+5.61%	+15.97%

Feb. 07	Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium	CI
Feb. 06	Diary - Europe's STOXX 600 Corporate Earnings Week Ahead	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
JOHNSON & JOHNSON	578B		BBB
ELI LILLY AND COMPANY	947B		A
ABBVIE INC.	395B		AA
ROCHE HOLDING AG	367B		AA
MERCK & CO., INC.	303B		A
ASTRAZENECA PLC	298B		A
NOVARTIS AG	295B		AAA
AMGEN INC.	207B		A
NOVO NORDISK A/S	208B		A
GILEAD SCIENCES, INC.	189B		AAA
PFIZER INC.	155B		BBB
BRISTOL-MYERS SQUIBB COMPANY	126B		A
GSK PLC	120B		AA
VERTEX PHARMACEUTICALS INCORPORATED	121B		AA
SANOFI	115B		A
CHUGAI PHARMACEUTICAL CO., LTD.	90.23B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
TAKEDA PHARMACEUTICAL COMPANY LIMITED	55.51B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	54.8B		AA
BAYER AG	53.15B		AA
Average	237.04B		AA
Weighted average by Cap.			AA